Biomarkers in acute coronary syndromes

Advances in Acute Coronary Syndrome Management

Volumn , Issue , 2012, Pages 19-29

  White, Harvey D ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956826710     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2217/EBO.11.333     Document Type: Chapter

References (28)

1. Thygesen K, Alpert JS, White HD et al. Universal definition of myocardial infarction. J. Am. Coll. Cardiol. 50, 2173-2195 (2007).
2. Okamatsu K, Takano M, Sakai S et al. Elevated troponin T levels and lesion characteristics in non-ST- elevation acute coronary syndromes. Circulation 109, 465-470 (2004).
3. Heeschen C, Hamm CW, Goldmann B et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM study investigators. Platelet receptor inhibition in ischemic syndrome management. Lancet 354, 1757-1762 (1999).
4. Morrow DA, Antman EM, Tanasijevic M et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J. Am. Coll. Cardiol. 36, 1812-1817 (2000).
5. Morrow DA, Cannon CP, Rifai N et al. Ability of minor elevations of troponins I or T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction. JAMA 286, 2405-2412 (2001).
6. Eggers KM, Jaffe AS, Lind L et al. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin. Chem. 55, 85-92 (2009).
7. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin. Chem. 55, 1303-1306 (2009).
8. White HD. Higher sensitivity troponin levels in the community: what do they mean and how will the diagnosis of myocardial infarction be made? Am. Heart J. 159, 933-936 (2010).
9. McCann CJ, Glover BM, Menown IB et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur. Heart J. 29, 2843-2850 (2008).
10. Reichlin T, Hochholzer W, Bassetti S et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 361, 858-867 (2009).
11. White HD, Chew DP. Acute myocardial infarction. Lancet 372, 570-584 (2008).
12. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J. Am. Coll. Cardiol. 57, 2406-2408 (2011).
13. Apple FS, Jesse RL, Newby LK et al. National academy of clinical biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 115, 352-355 (2007).
14. Frankenstein L, Wu AH, Hallermayer K et al. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin. Chem. 57, 1068-1071 (2011).
15. Vasile VC, Saenger AK, Kroning JM et al. Biological and analytical variability of a novel high-sensitivity cardiac 21 troponin T assay. Clin. Chem. 56, 1086-1090 (2010).
16. Wu AH, Lu QA, Todd J et al. Short- and long-term biological variation in cardiac troponin I measured with a high- sensitivity assay: implications for clinical practice. Clin. Chem. 22 55, 52-58 (2009).
17. Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am. J. Clin. Pathol. 128, 282-286 (2007).
18. Body R, Carley S, McDowell G et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-23 sensitivity assay. J. Am. Coll. Cardiol. 58, 1332-1339 (2011).
19. Reichlin T, Irfan A, Twerenbold R et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction/clinical perspective. Circulation 124, 136-145 (2011).
20. Omland T, de Lemos JA, Sabatine MS et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N. Engl. J. Med. 361, 2538-2547 (2009).
21. Mills NL, Churchhouse AM, Lee KK et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 305, 1210-1216 (2011)
22. Hamm CW, Bassand JP, Agewall S et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC). Eur. Heart J. 32,(23), 2999-3054 (2011).
23. de Lemos JA, Morrow DA. Brain natriuretic peptide measurement in acute coronary syndromes. Circulation 106, 2868-2870 (2002).
24. Heeschen C, Hamm CW, Mitrovic V et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110, 3206-3212 (2004).
25. Peacock F, Morris DL, Anwaruddin S et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am. Heart J. 152, 253-262 (2006).
26. Sabatine MS, Morrow DA, de Lemos JA et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105, 1760-1763 (2002).
27. Dhillon OS, Narayan HK, Quinn PA et al. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with global registry of acute coronary events risk scoring and NT-proBNP. Am. Heart J. 161, 1163-1170 (2011).
28. Wollert KC, Kempf T, Lagerqvist B et al. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST- elevation acute coronary syndrome. Circulation 116, 1540-1548 (2007).